Wednesday November 25, 2020, 08:30 - 12:00
Thursday November 26, 2020, 08:30 - 12:00

In total, five (5) hours of continuing education eligible with the OPQ * will be recognized for participants who attended the webconferences live (2.5 hours for each of the two half-days).

Companies with access to new technologies (omics, bioinformatics, computational biology, artificial intelligence) have seen a notable increase in the quantity and quality of data and knowledge in the field of life sciences.

In prevention and treatment contexts,

Dissemination what to do with these today? Do we have the tools and resources or should we develop them in order to have access to this wealth of massive data?

With the participation of renowned specialists, the objective of this major conference will be to understand the extent of the use of big data, from its generation to its integration into our healthcare system.

It will also address budgetary, regulatory, ethical and clinical adoption aspects, all essential for their generation and optimal use.


Dates: Wednesday 25 and Thursday 26 November 2020
Time: 8:30 a.m. to 12 p.m.
Location :

Live web

Who is this conference for?

Researchers, professors, clinicians, graduate students, decision-makers and professionals in the health and pharmaceutical industries.

Some conferences may be held in English. If necessary, they will be identified in the programming.


Fundamentals and Practices of High Definition Medicine

Joni L. Rutter, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH)
Vincent Mooser, Canada Research Chair of Excellence in Genomic Medicine, McGill University

High Definition Medicine – Usefulness of MHD to Address Immune System Challenges

Karl Weiss, Department of Microbiology, Infectiology and Immunology, University of Montreal
Claude Perreault, Institute for Research in Immunology and Cancer
Michele D’Elia, Medical Affairs, Roche Diagnostics

Examples of applications of personalized medicine by experts:
from basic research to application

Jean-Claude Tardif, Research Center of the Montreal Heart Institute
Pavel Hamet, Department of Medicine – Cell Biology, Endocrinology and Genetics, University of Montreal
Denis-Claude Roy, Department of Medicine – Hematology and Immunology, University of Montreal
Nada Jabado, Department of Pediatrics, McGill University

Innovation in the era of high definition medicine

Rémi Quirion, Chief Scientist of Quebec



We suggest